HU
Hua Medicine (Shanghai) Ltd.
HUMDF · OTC
$0.30 +0.00% (+$0.00)
1M -1.98%
Market Cap ¥2.03B
P/E Ratio 1.88x
Div. Yield -
ROE 147.48%
Bulios Fair Price
$0.34
11.9% upside
Current Price
$0.3
Undervalued Fair Value Overvalued
According to Bulios Fair Price, HUMDF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
83 /100
Cheap P/S 4.23x
P/B 2.02x
P/E 1.88x
Growth
100 /100
Growing Book val. growth 53.29%
Rev. growth 201.06%
FCF growth N/A
Profitability
40 /100
Moderate FCF margin 12.43%
Op. margin 29.39%
Gross margin 56.87%
Quality
49 /100
Average Asset turnover 0.33x
ROA 73.30%
ROIC 10.78%
Debt
69 /100
Low Current ratio 6.17x
Int. coverage -17.79x
Debt/Equity 0.30x
Stability
28 /100
Unstable Profitable years 1
EPS volatility 305.57%
Beta 0.74x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about HUMDF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Li Chen
Employees
328
Headquarters
Shanghai
Upcoming events
01 APR
Earnings
Upcoming earnings report